Skip to content

Sio Capital Management, LLC

Follow

13F filer, CIK 1482416, NEW YORK, NY

Sio Capital Management, LLC reported $528,521,218 across 55 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 50.96% of the portfolio.

Accepted , ingested 13F-HR 0001214659-26-014302

Period
2026-09-30
Reported value
$529M
Holdings
55
Top 10 weight
50.96%
New
15
Sold out
19

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MRKnew+145,485$21.1M
GMEDadded+174,293$13.1M
REPLnew+865,331$11.5M
GSKadded+234,421$11.3M
BMRNnew+174,311$10.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CORexited-173,588-$49.1M
MMSreduced-446,987-$23.8M
TYRAexited-695,315-$22.2M
WAYexited-925,834-$19M
ORKAexited-177,118-$16.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001214659-26-014302, largest first. % of portfolio is the value over $469,755,891, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,370,000 shares; 2025Q1: 2,369,960 shares; 2025Q2: 1,839,022 shares; 2025Q3: 1,772,601 shares; 2025Q4: 1,874,641 shares; 2026Q1: 5,382,965 shares; 2026Q2: 5,545,984 shares; 2026Q3: 5,179,464 shares 5,179,464$40.2M8.57%-366,520Timeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 207,000 shares; 2025Q2: 245,570 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 301,816 shares; 2026Q3: 476,109 shares 476,109$35.7M7.59%+174,293Timeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 268,873 shares; 2025Q4: not reported; 2026Q1: 385,879 shares; 2026Q2: 436,700 shares; 2026Q3: 671,121 shares 671,121$32.3M6.88%+234,421Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 195,500 shares; 2025Q1: 203,311 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 127,202 shares; 2026Q1: 306,358 shares; 2026Q2: 88,186 shares; 2026Q3: 140,999 shares 140,999$24M5.1%+52,813Timeline
SENSSENSEONICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 115,784 shares; 2026Q1: 115,784 shares; 2026Q2: 1,592,692 shares; 2026Q3: 2,290,860 shares 2,290,860$23.3M4.96%+698,168Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 270,596 shares; 2025Q2: 173,951 shares; 2025Q3: 177,300 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 145,485 shares 145,485$21.1M4.5%newTimeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 123,000 shares; 2025Q1: 123,000 shares; 2025Q2: 124,230 shares; 2025Q3: 124,230 shares; 2025Q4: 75,730 shares; 2026Q1: not reported; 2026Q2: 480,383 shares; 2026Q3: 500,117 shares 500,117$19.2M4.09%+19,734Timeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 387,000 shares; 2025Q1: not reported; 2025Q2: 187,500 shares; 2025Q3: 562,703 shares; 2025Q4: 971,686 shares; 2026Q1: 239,671 shares; 2026Q2: 364,200 shares; 2026Q3: 356,182 shares 356,182$14.7M3.13%-8,018Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,323,431 shares; 2026Q3: 9,104,151 shares 9,104,151$14.6M3.1%-4,219,280Timeline
MMSMAXIMUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 381,423 shares; 2025Q1: 468,352 shares; 2025Q2: 548,086 shares; 2025Q3: 557,615 shares; 2025Q4: 500,304 shares; 2026Q1: 768,825 shares; 2026Q2: 715,267 shares; 2026Q3: 268,280 shares 268,280$14.3M3.04%-446,987Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 965,000 shares; 2026Q2: 1,003,562 shares; 2026Q3: 3,629,844 shares 3,629,844$13.7M2.91%+2,626,282Timeline
VTRSVIATRIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 730,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 954,299 shares; 2026Q3: 755,490 shares 755,490$13.4M2.85%-198,809Timeline
AVAHAVEANNA HEALTHCARE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 369,036 shares; 2026Q3: 1,012,102 shares 1,012,102$12.6M2.67%+643,066Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 720,036 shares; 2026Q2: not reported; 2026Q3: 865,331 shares 865,331$11.5M2.44%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 208,500 shares; 2026Q3: 428,860 shares 428,860$10.7M2.28%+220,360Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 160,051 shares; 2025Q1: 87,298 shares; 2025Q2: 112,923 shares; 2025Q3: 55,723 shares; 2025Q4: 87,272 shares; 2026Q1: 265,543 shares; 2026Q2: 97,305 shares; 2026Q3: 146,268 shares 146,268$10.6M2.26%+48,963Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 141,134 shares; 2025Q2: 225,114 shares; 2025Q3: 225,114 shares; 2025Q4: 232,688 shares; 2026Q1: 194,226 shares; 2026Q2: not reported; 2026Q3: 174,311 shares 174,311$10.5M2.23%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 786,526 shares; 2025Q4: 477,067 shares; 2026Q1: 193,843 shares; 2026Q2: 110,022 shares; 2026Q3: 126,339 shares 126,339$10M2.14%+16,317Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 61,848 shares 61,848$9.99M2.13%newTimeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 185,265 shares; 2025Q4: 185,265 shares; 2026Q1: 366,809 shares; 2026Q2: 307,657 shares; 2026Q3: 291,231 shares 291,231$9.79M2.08%-16,426Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,054,651 shares; 2025Q1: 473,607 shares; 2025Q2: 478,343 shares; 2025Q3: 478,343 shares; 2025Q4: 478,343 shares; 2026Q1: 1,498,620 shares; 2026Q2: 1,075,274 shares; 2026Q3: 873,375 shares 873,375$9.76M2.08%-201,899Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 98,003 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 172,203 shares; 2026Q1: not reported; 2026Q2: 57,750 shares; 2026Q3: 33,935 shares 33,935$9.22M1.96%-23,815Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 158,053 shares 158,053$8.93M1.9%newTimeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 282,000 shares 282,000$8.53M1.82%newTimeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,300,000 shares; 2026Q3: 561,289 shares 561,289$6.9M1.47%-738,711Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,437,500 shares; 2025Q1: 1,514,300 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,715,394 shares; 2026Q1: 1,969,839 shares; 2026Q2: 1,921,872 shares; 2026Q3: 1,991,339 shares 1,991,339$6.07M1.29%+69,467Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,572,167 shares; 2025Q1: 3,735,396 shares; 2025Q2: 3,735,396 shares; 2025Q3: 2,636,548 shares; 2025Q4: 2,636,548 shares; 2026Q1: 3,076,580 shares; 2026Q2: 2,634,137 shares; 2026Q3: 3,634,137 shares 3,634,137$6.07M1.29%+1,000,000Timeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 391,629 shares; 2025Q2: 947,489 shares; 2025Q3: 1,498,095 shares; 2025Q4: 993,095 shares; 2026Q1: 1,922,887 shares; 2026Q2: 1,486,175 shares; 2026Q3: 1,278,056 shares 1,278,056$5.92M1.26%-208,119Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 82,900 shares 82,900$5.37M1.14%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 766,364 shares 766,364$5.23M1.11%newTimeline
RNAQURAINIER ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000$5.1M1.09%newTimeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 697,413 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 529,155 shares 529,155$4.38M0.93%newTimeline
SERSERINA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 2,000,000 shares 2,000,000$4M0.85%+1,000,000Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 451,793 shares; 2025Q1: 507,562 shares; 2025Q2: 512,338 shares; 2025Q3: 190,764 shares; 2025Q4: 81,883 shares; 2026Q1: 86,083 shares; 2026Q2: 73,952 shares; 2026Q3: 75,152 shares 75,152$3.74M0.8%+1,200Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,747 shares; 2025Q1: 719,654 shares; 2025Q2: 726,851 shares; 2025Q3: 726,851 shares; 2025Q4: 613,888 shares; 2026Q1: 613,888 shares; 2026Q2: 617,675 shares; 2026Q3: 657,104 shares 657,104$3.39M0.72%+39,429Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,078,965 shares; 2026Q2: 1,078,965 shares; 2026Q3: 1,082,965 shares 1,082,965$2.95M0.63%+4,000Timeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 657,200 shares; 2026Q2: 529,933 shares; 2026Q3: 548,103 shares 548,103$2.92M0.62%+18,170Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 165,110 shares; 2026Q2: 124,168 shares; 2026Q3: 132,097 shares 132,097$2.84M0.6%+7,929Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 331,730 shares; 2026Q2: 208,557 shares; 2026Q3: 95,457 shares 95,457$2.57M0.55%-113,100Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 2,232,000 shares; 2025Q2: 2,232,000 shares; 2025Q3: 1,427,495 shares; 2025Q4: 1,427,495 shares; 2026Q1: 1,252,381 shares; 2026Q2: 1,005,334 shares; 2026Q3: 1,005,334 shares 1,005,334$2.5M0.53%0Timeline
ALGSALIGOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 180,720 shares; 2025Q2: 335,937 shares; 2025Q3: 335,937 shares; 2025Q4: 335,937 shares; 2026Q1: 327,237 shares; 2026Q2: 327,237 shares; 2026Q3: 327,237 shares 327,237$1.84M0.39%0Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 382,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 481,601 shares 481,601$1.78M0.38%newTimeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 184,424 shares 184,424$1.5M0.32%newTimeline
XLOXILIO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 152,464 shares; 2026Q2: 152,464 shares; 2026Q3: 152,464 shares 152,464$1.38M0.29%0Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 721,785 shares; 2026Q2: 623,130 shares; 2026Q3: 373,666 shares 373,666$1.22M0.26%-249,464Timeline
QTIQT IMAGING HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 15,236 shares; 2026Q3: 440,446 shares 440,446$1.12M0.24%+425,210Timeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 740,000 shares; 2026Q1: 904,268 shares; 2026Q2: 904,268 shares; 2026Q3: 904,268 shares 904,268$1.07M0.23%0Timeline
TELATELA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 630,000 shares; 2025Q1: 630,000 shares; 2025Q2: 636,300 shares; 2025Q3: 636,300 shares; 2025Q4: 636,300 shares; 2026Q1: 636,300 shares; 2026Q2: 636,300 shares; 2026Q3: 636,300 shares 636,300$732K0.16%0Timeline
ENVBENVERIC BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 180,000 shares; 2026Q3: 330,000 shares 330,000$490K0.1%+150,000Timeline
NMTCNEUROONE MED TECHNOLOGIES COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 82,767 shares; 2026Q3: 82,767 shares 82,767$85.2K0.02%0Timeline
MODDMODULAR MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 26,190 shares; 2026Q2: 26,190 shares; 2026Q3: 26,190 shares 26,190$52.4K0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MRKMERCK & CO INC COMput150,000$21.8Mnew
PFEPFIZER INC COMput600,000$17.1Mnew
SLSSELLAS LIFE SCIENCES GROUP I COM NEWput1,230,700$15.1M0
HAEHAEMONETICS CORP MASS Stockput44,700$4.71Mnew

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CORCENCORA INC173,588$49.1Mshares
TYRATYRA BIOSCIENCES INC695,315$22.2Mshares
WAYWAYSTAR HLDG CORP925,834$19Mshares
ORKAORUKA THERAPEUTICS INC177,118$16.9Mshares
CCRNCROSS CTRY HEALTHCARE INC1,098,393$14.5Mshares
ABTABBOTT LABORATORIES128,656$11.7Mshares
ZBHZIMMER BIOMET HOLDINGS INC131,445$11.3Mshares
REGNREGENERON PHARMACEUTICALS18,000$11.2Mshares
BMYBRISTOL-MYERS SQUIBB CO193,500$11.1Mshares
MDTMEDTRONIC PLC142,500$11.1Mshares
DNTHDIANTHUS THERAPEUTICS INC59,254$5.78Mshares
SIONSIONNA THERAPEUTICS INC127,808$5.62Mshares
OCULOCULAR THERAPEUTIX INC539,493$5.3Mshares
HIMSHIMS & HERS HEALTH INC75,000$2.6Mcall
AORTARTIVION INC48,481$1.09Mshares
BBOTBRIDGEBIO ONCOLOGY THERAPEUT130,628$995Kshares
ADGMADAGIO MED HLDGS INC698,989$455Kshares
RCKTWROCKET PHARMACEUTICALS INC400,000$1.48Kshares
HUMAWHUMACYTE INC49,998$477shares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-26-014302 base2026-11-16